Strategies for biopharma in integrating agentic AI—to achieve incremental gains in efficiency, while delivering meaningful ...

Coherent Corp’s (COHR) outlook has led to a re-evaluation of its investment potential following its Q4 report, with analyst Chris Lau seeing opportunity despite the market’s negative reaction.